ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On January 8, 2024, Medable Inc., a technology provider for clinical trials, introduced a new automation technology applied across its clinical trials platform that is designed to cut standard trial build timelines. By automating manual tasks such as testing, Medable Inc.'s new technology aims to save time and remove electronic clinical outcomes assessment (eCOA) from the critical path to trial go-live.
• In October 2023, Clario, a healthcare research technology company, announced a strategic partnership with Trial Data, a leading decentralized clinical trial (DCT) service provider, to bring innovative decentralized clinical trials solutions to the Chinese market and advance patient-centric clinical trials in China. This collaboration combines vast DCT experience and eCOA solutions, along with deep clinical trial operations experience in China, resulting in increased capabilities and flexibility in clinical trial strategies for sponsors supporting clinical trials in China.
• In September 2023, THREAD, Inc., a medical technology company, announced the launch of a suite of new complex electronic clinical outcome assessment (eCOA) features, including an expanded global library, to its decentralized research platform serving global researchers
• In December 2022, Suvoda LLC, an eCOA clinical trial technology company, announced that it had introduced the electronic clinical outcome assessments (eCOA) design toolkit, as the solution moves to the Early Adopter programme’s second phase. The toolkit is created to integrate smoothly with Suvoda IRT and eConsent, and also address the historical inadequacies that still impact eCOA.